Canaccord Commences Coverage, page-5

Thanks for highlighting Haplo.

I am in the process of working my way through the document, which I confirm reads generally very bullish. But the absence of significant comment since your first post in this thread was creating concern that the bulk of TAW posters must be under some kind of Medical Mary Jane state and so unable to offer a considered comment.

Cannacord (with acknowledged bias) is ticking all the boxes highlighted in prior TAW anns.

Leading to my professional summary ..."what's not to like???"

Lithium consumers, meet a supplier ready to talk delivery.

DYOR